Hanson & Doremus Investment Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $389K | Sell |
1,760
-120
| -6% | -$33.2K | 0.04% | 154 |
|
|
2026
Q1 | $555K | Hold |
1,880
| – | – | 0.06% | 121 |
|
|
2025
Q4 | $513K | Sell |
1,880
-55
| -3% | -$14.9K | 0.06% | 113 |
|
|
2025
Q3 | $523K | Buy |
1,935
+19
| +1% | +$5.17K | 0.07% | 113 |
|
|
2025
Q2 | $528K | Hold |
1,916
| – | – | 0.07% | 109 |
|
|
2025
Q1 | $508K | Hold |
1,916
| – | – | 0.07% | 112 |
|
|
2024
Q4 | $445K | Hold |
1,916
| – | – | 0.07% | 113 |
|
|
2024
Q3 | $423K | Sell |
1,916
-67
| -3% | -$13.9K | 0.07% | 119 |
|
|
2024
Q2 | $390K | Sell |
1,983
-56
| -3% | -$11.6K | 0.07% | 125 |
|
|
2024
Q1 | $439K | Sell |
2,039
-78
| -4% | -$16.4K | 0.08% | 119 |
|
|
2023
Q4 | $446K | Hold |
2,117
| – | – | 0.08% | 115 |
|
|
2023
Q3 | $424K | Hold |
2,117
| – | – | 0.09% | 119 |
|
|
2023
Q2 | $392K | Sell |
2,117
-189
| -8% | -$34.9K | 0.08% | 121 |
|
|
2023
Q1 | $442K | Sell |
2,306
-284
| -11% | -$51.4K | 0.1% | 115 |
|
|
2022
Q4 | $436K | Buy |
2,590
+368
| +17% | +$64K | 0.09% | 127 |
|
|
2022
Q3 | $394K | Hold |
2,222
| – | – | 0.1% | 117 |
|
|
2022
Q2 | $455K | Sell |
2,222
-182
| -8% | -$38.6K | 0.11% | 119 |
|
|
2022
Q1 | $572K | Hold |
2,404
| – | – | 0.12% | 113 |
|
|
2021
Q4 | $549K | Hold |
2,404
| – | – | 0.12% | 115 |
|
|
2021
Q3 | $465K | Sell |
2,404
-862
| -26% | -$175K | 0.11% | 119 |
|
|
2021
Q2 | $546K | Buy |
3,266
+749
| +30% | +$158K | 0.16% | 101 |
|
|
2021
Q1 | $514K | Sell |
2,517
-329
| -12% | -$64.8K | 0.12% | 120 |
|
|
2020
Q4 | $518K | Sell |
2,846
-420
| -13% | -$71.4K | 0.13% | 113 |
|
|
2020
Q3 | $546K | Sell |
3,266
-119
| -4% | -$20K | 0.16% | 101 |
|
|
2020
Q2 | $550K | Hold |
3,385
| – | – | 0.17% | 102 |
|
|
2020
Q1 | $585K | Sell |
3,385
-61
| -2% | -$12.1K | 0.2% | 92 |
|
|
2019
Q4 | $692K | Sell |
3,446
-47
| -1% | -$9.64K | 0.2% | 99 |
|
|
2019
Q3 | $738K | Sell |
3,493
-129
| -4% | -$27K | 0.23% | 91 |
|
|
2019
Q2 | $703K | Sell |
3,622
-138
| -4% | -$25.4K | 0.22% | 93 |
|
|
2019
Q1 | $619K | Sell |
3,760
-112
| -3% | -$19.8K | 0.2% | 97 |
|
|
2018
Q4 | $728K | Sell |
3,872
-345
| -8% | -$63.7K | 0.26% | 86 |
|
|
2018
Q3 | $718K | Hold |
4,217
| – | – | 0.22% | 96 |
|
|
2018
Q2 | $691K | Hold |
4,217
| – | – | 0.23% | 99 |
|
|
2018
Q1 | $682K | Sell |
4,217
-218
| -5% | -$34.7K | 0.21% | 104 |
|
|
2017
Q4 | $648K | Hold |
4,435
| – | – | 0.22% | 105 |
|
|
2017
Q3 | $602K | Hold |
4,435
| – | – | 0.21% | 110 |
|
|
2017
Q2 | $555K | Hold |
4,435
| – | – | 0.21% | 110 |
|
|
2017
Q1 | $527K | Hold |
4,435
| – | – | 0.21% | 108 |
|
|
2016
Q4 | $512K | Sell |
4,435
-95
| -2% | -$10.6K | 0.22% | 107 |
|
|
2016
Q3 | $473K | Hold |
4,530
| – | – | 0.22% | 105 |
|
|
2016
Q2 | $441K | Hold |
4,530
| – | – | 0.2% | 109 |
|
|
2016
Q1 | $435K | Hold |
4,530
| – | – | 0.2% | 113 |
|
|
2015
Q4 | $410K | Sell |
4,530
-85
| -2% | -$8K | 0.19% | 120 |
|
|
2015
Q3 | $428K | Sell |
4,615
-100
| -2% | -$9.51K | 0.21% | 114 |
|
|
2015
Q2 | $439K | Hold |
4,715
| – | – | 0.19% | 121 |
|
|
2015
Q1 | $447K | Hold |
4,715
| – | – | 0.19% | 120 |
|
|
2014
Q4 | $418K | Hold |
4,715
| – | – | 0.18% | 127 |
|
|
2014
Q3 | $377K | Hold |
4,715
| – | – | 0.17% | 133 |
|
|
2014
Q2 | $335K | Hold |
4,715
| – | – | 0.15% | 139 |
|
|
2014
Q1 | $349K | Hold |
4,715
| – | – | 0.16% | 134 |
|
|
2013
Q4 | $370K | Hold |
4,715
| – | – | 0.18% | 126 |
|
|
2013
Q3 | $348K | Hold |
4,715
| – | – | 0.18% | 126 |
|
|
2013
Q2 | $358K | Buy |
+4,715
| New | +$309K | 0.2% | 114 |
|
Other funds holding CME
Hanson & Doremus Investment Management's CME Position: Q2 2026 in Review
Hanson & Doremus Investment Management reduced its CME Group (CME) stake by 6.4% in Q2 2026, selling an estimated $33.2K and leaving 1,760 shares worth $389K. The position accounts for 0.04% of the portfolio, ranked #154.
Hanson & Doremus Investment Management first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $738K in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Hanson & Doremus Investment Management held 1,760 shares of CME Group worth $389K as of Q2 2026.
- Hanson & Doremus Investment Management sold 120 CME Group shares in Q2 2026, an estimated $33.2K.
- CME Group made up 0.04% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #154 holding.
- Hanson & Doremus Investment Management first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
- Hanson & Doremus Investment Management's CME Group position peaked at $738K in Q3 2019.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.